Tandem closes IPO; Particle Sciences to develop nasal brain injury formulation for BHR Pharma;

> Tandem Diabetes Care ($TNDM) closed its IPO of 9.2 million shares at $15 per share. More (sub. req.)

> BHR Pharma tapped delivery tech company Particle Sciences to develop and manufacture a nasal formulation of progesterone for traumatic brain injury. More

> 3M Drug Delivery Systems will provide a matrix patch for the transdermal delivery of the opioid pain medication fentanyl to German company STADA Arzneimittel AG. More

> Nonprofit research institute CBSET has installed GE Healthcare's ($GE) Innova 3-D imaging system for real-time interventional imaging that also allows for drug delivery capabilities. Release

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.